Articles related to BUSINESS & POLICY

“Prior authorization began as a reasonable mechanism for controlling costs, but over the decades, I have been practicing it has ballooned into a massive administrative burden that far too often leads to care delays and unnecessary agony and harm.” – René Bravo, MD, President of the California Medical Association (CMA)

“This acquisition immediately advances Biogen’s ongoing transformation… with two approved, best-in-class medicines that complement our existing portfolio.”
— Christopher Viehbacher, President and CEO, Biogen

“The goal is to advance scientific rigor, cultural inclusivity, and adaptability while ensuring that the DSM remains useful to clinicians and remains a trusted, relevant tool for understanding and treating mental disorders.” – Marketa M. Wills, MD, MBA

“ACP believes it is important for patients and clinicians to have robust vaccine recommendations based on science rather than politics.” — Goldman, Mitchell & Hopkins, Annals of Internal Medicine

“The lived experience of youth who identify as TGD cannot be ignored and the belief that all youth have the inherent right to mental health care — regardless of gender or gender-identity — is reaffirmed.”

“The system lacks transparency, which was the main intent of the Sunshine Act.” — Krishna Nalleballe, MD, University of Arkansas for Medical Sciences